NOVAVAX INC (NVAX)

US6700024010 - Common Stock

4.78  -0.07 (-1.44%)

After market: 4.76 -0.02 (-0.42%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
983.71M1.98B1.15B475.60M18.70M
Cost Of Goods
343.27M902.60MN/AN/AN/A
Gross Profit
640.44M1.08BN/AN/AN/A
Operating Expenses
1.19B1.72B2.83B892.30M148.20M
Research and Development
735.20M1.24B2.53B747.00M113.80M
Selling, General, and Administrative Expenses
457.45M488.70M298.40M145.30M34.40M
Operating Income
-552.21M-644.70M-1.69B-416.70M-129.60M
Interest Income/Expense
-14.42M-19.90M-27.00M-14.10M-12.10M
Other Income/Expense
37.90M11.00M-1.00M12.60M0.00
Non Recurring Items
-14.30MN/A0.000.009.00M
Income Before Taxes
-543.03M-653.60M-1.71B-418.30M-132.70M
Income Tax
2.03M4.30M29.20MN/AN/A
Net Income
-545.06M-657.90M-1.74B-418.30M-132.70M
EBITDA
-510.99M-615.60M-1.67B-411.80M-123.90M
 
Per Share Data
EPS Diluted Total Ops
-5.41-8.42-23.44-7.27-5.51
Non GAAP EPS
-5.53-8.40-23.29-6.79-6.13
 
Statistics
Gross Profit Margin
65.10%54.45%N/AN/AN/A
Profit Margin
-55.41%-33.20%-152.12%-87.95%-709.63%
Operating Profit Margin
-56.14%-32.53%-147.13%-87.62%-693.05%

All data in USD

Charts